Stock listing
NSE:DIVISLAB Divi's Laboratories Limited Share Price
Home listing (NSE) of Divi's Laboratories Limited
Follow Divi's Laboratories Limited into a list and get an email when it puts out news.
Share price · NSE:DIVISLAB
₹11,181 INR +132 (+1.2%)
Close on Nov 20, 2026
Past year +73.0% · daily closes, Nov 20, 2025 – Nov 20, 2026, adjusted for splits- Day range
- ₹11,025 – ₹11,198 INRNov 20, 2026
- Volume
- 404,820 sharesNov 20, 2026
- Market cap
- ₹2.97T INRAt the close on Nov 20, 2026 · price × 265.5M shares outstanding
- 52-week range
- ₹5,647.50 – ₹11,824 INRLowest and highest trades, Nov 21, 2025 – Nov 20, 2026
- Traded on an average day
- ₹5.88B INRMedian day 531,107 shares · 2 days with no trades · last 3 months, Aug 20, 2026 – Nov 20, 2026
Prices by listing
| Listing | Last | Change | Volume | Open | High | Low | Previous close | Price from |
|---|
| NSE:DIVISLAB · Home | ₹11,181 INR | +132 (+1.2%) | 404,820 | ₹11,125 | ₹11,198 | ₹11,025 | ₹11,049 | Close on Nov 20, 2026 |
|---|
Daily closes
Last 3 months, Aug 20, 2026 – Nov 20, 2026 · NSE:DIVISLAB · INR, adjusted for splits
| Day | Close | Change | % | Open | High | Low | Volume |
|---|
| ₹11,181 | +132 | +1.2% | ₹11,125 | ₹11,198 | ₹11,025 | 404,820 |
|---|
| ₹11,049 | -101 | -0.9% | ₹11,180 | ₹11,265 | ₹11,049 | 472,664 |
|---|
| ₹11,150 | +70 | +0.6% | ₹11,087 | ₹11,208 | ₹11,030 | 727,533 |
|---|
| ₹11,080 | -362 | -3.2% | ₹11,490 | ₹11,545 | ₹10,954 | 903,606 |
|---|
| ₹11,442 | -43 | -0.4% | ₹11,412 | ₹11,646 | ₹11,351 | 536,386 |
|---|
| ₹11,485 | +118 | +1.0% | ₹11,329 | ₹11,485 | ₹11,272 | 728,927 |
|---|
| ₹11,367 | -199 | -1.7% | ₹11,760 | ₹11,801 | ₹11,190 | 1,602,392 |
|---|
| ₹11,566 | +1,245 | +12.1% | ₹11,097 | ₹11,824 | ₹11,071 | 2,586,198 |
|---|
| ₹10,321 | +180 | +1.8% | ₹10,130 | ₹10,321 | ₹10,041 | 885,883 |
|---|
| ₹10,141 | +103 | +1.0% | ₹10,100 | ₹10,159 | ₹9,888.00 | 837,076 |
|---|
| ₹10,038 | -27 | -0.3% | ₹10,060 | ₹10,067 | ₹9,946.00 | 534,906 |
|---|
| ₹10,064 | +119 | +1.2% | ₹9,965.00 | ₹10,064 | ₹9,863.00 | 611,299 |
|---|
| ₹9,945.50 | +166 | +1.7% | ₹9,900.00 | ₹9,990.00 | ₹9,868.00 | 914,466 |
|---|
| ₹9,780.00 | +116 | +1.2% | ₹9,680.00 | ₹9,865.00 | ₹9,621.50 | 1,027,168 |
|---|
| ₹9,664.00 | +106 | +1.1% | ₹9,563.00 | ₹9,685.50 | ₹9,534.00 | 395,170 |
|---|
| ₹9,558.50 | +53 | +0.6% | ₹9,460.00 | ₹9,699.50 | ₹9,370.00 | 744,981 |
|---|
| ₹9,505.50 | +456 | +5.0% | ₹9,090.00 | ₹9,505.50 | ₹9,067.00 | 802,563 |
|---|
| ₹9,050.00 | +100 | +1.1% | ₹8,900.00 | ₹9,080.00 | ₹8,860.00 | 576,041 |
|---|
| ₹8,950.00 | -212 | -2.3% | ₹9,165.00 | ₹9,175.50 | ₹8,797.00 | 620,239 |
|---|
| ₹9,162.00 | -28 | -0.3% | ₹9,114.00 | ₹9,190.00 | ₹9,006.50 | 1,040,584 |
|---|
| ₹9,190.00 | +103 | +1.1% | ₹9,190.00 | ₹9,243.00 | ₹9,041.00 | 685,478 |
|---|
| ₹9,087.00 | -58 | -0.6% | ₹9,191.50 | ₹9,323.50 | ₹9,045.00 | 448,972 |
|---|
| ₹9,144.50 | +115 | +1.3% | ₹9,030.50 | ₹9,248.00 | ₹8,985.50 | 778,528 |
|---|
| ₹9,030.00 | +7 | +0.1% | ₹9,085.00 | ₹9,124.50 | ₹8,950.00 | 645,244 |
|---|
| ₹9,023.00 | -262 | -2.8% | ₹9,315.00 | ₹9,315.00 | ₹8,937.50 | 992,022 |
|---|
| ₹9,285.00 | -141 | -1.5% | ₹9,411.00 | ₹9,423.50 | ₹9,164.50 | 416,650 |
|---|
| ₹9,426.00 | +86 | +0.9% | ₹9,346.00 | ₹9,431.50 | ₹9,297.00 | 358,499 |
|---|
| ₹9,340.00 | -21 | -0.2% | ₹9,417.00 | ₹9,460.50 | ₹9,273.00 | 378,861 |
|---|
| ₹9,361.00 | -227 | -2.4% | ₹9,588.00 | ₹9,658.00 | ₹9,355.00 | 441,895 |
|---|
| ₹9,588.00 | +38 | +0.4% | ₹9,500.50 | ₹9,660.00 | ₹9,494.00 | 422,217 |
|---|
| ₹9,550.00 | +354 | +3.8% | ₹9,210.00 | ₹9,557.50 | ₹9,165.00 | 465,106 |
|---|
| ₹9,196.00 | -53 | -0.6% | ₹9,251.00 | ₹9,285.50 | ₹9,113.50 | 480,338 |
|---|
| ₹9,249.00 | 0 | 0.0% | ₹9,249.00 | ₹9,249.00 | ₹9,249.00 | 0 |
|---|
| ₹9,249.00 | -43 | -0.5% | ₹9,277.00 | ₹9,318.00 | ₹9,078.00 | 567,310 |
|---|
| ₹9,291.50 | -140 | -1.5% | ₹9,499.50 | ₹9,505.00 | ₹9,275.00 | 541,269 |
|---|
| ₹9,431.00 | -119 | -1.2% | ₹9,562.00 | ₹9,610.50 | ₹9,431.00 | 652,089 |
|---|
| ₹9,550.00 | -70 | -0.7% | ₹9,600.00 | ₹9,655.00 | ₹9,473.00 | 380,253 |
|---|
| ₹9,619.50 | +18 | +0.2% | ₹9,602.00 | ₹9,668.50 | ₹9,530.00 | 388,859 |
|---|
| ₹9,602.00 | -22 | -0.2% | ₹9,540.50 | ₹9,740.00 | ₹9,540.00 | 666,667 |
|---|
| ₹9,624.00 | +272 | +2.9% | ₹9,330.00 | ₹9,624.00 | ₹9,312.50 | 489,382 |
|---|
| ₹9,352.00 | -59 | -0.6% | ₹9,444.00 | ₹9,444.00 | ₹9,315.50 | 293,688 |
|---|
| ₹9,410.50 | +36 | +0.4% | ₹9,418.00 | ₹9,461.50 | ₹9,375.50 | 380,343 |
|---|
| ₹9,375.00 | +52 | +0.6% | ₹9,346.50 | ₹9,445.00 | ₹9,328.50 | 691,534 |
|---|
| ₹9,323.00 | +165 | +1.8% | ₹9,158.00 | ₹9,371.00 | ₹9,135.50 | 494,167 |
|---|
| ₹9,158.00 | -40 | -0.4% | ₹9,168.00 | ₹9,180.00 | ₹8,923.00 | 878,300 |
|---|
| ₹9,198.00 | -124 | -1.3% | ₹9,367.50 | ₹9,397.50 | ₹9,118.50 | 380,826 |
|---|
| ₹9,322.00 | 0 | 0.0% | ₹9,322.00 | ₹9,322.00 | ₹9,322.00 | 0 |
|---|
| ₹9,322.00 | -117 | -1.2% | ₹9,370.00 | ₹9,415.00 | ₹9,310.50 | 516,756 |
|---|
| ₹9,438.50 | -50 | -0.5% | ₹9,600.50 | ₹9,604.00 | ₹9,386.50 | 338,181 |
|---|
| ₹9,488.00 | -87 | -0.9% | ₹9,575.00 | ₹9,615.00 | ₹9,410.00 | 385,273 |
|---|
| ₹9,575.00 | +260 | +2.8% | ₹9,375.50 | ₹9,588.00 | ₹9,253.00 | 838,906 |
|---|
| ₹9,315.00 | +215 | +2.4% | ₹9,119.50 | ₹9,315.00 | ₹9,119.50 | 502,162 |
|---|
| ₹9,100.00 | -150 | -1.6% | ₹9,244.00 | ₹9,269.00 | ₹9,100.00 | 250,202 |
|---|
| ₹9,250.00 | +30 | +0.3% | ₹9,253.00 | ₹9,282.00 | ₹9,184.00 | 497,269 |
|---|
| ₹9,220.00 | +55 | +0.6% | ₹9,121.50 | ₹9,299.00 | ₹9,104.50 | 403,619 |
|---|
| ₹9,165.00 | -302 | -3.2% | ₹9,251.50 | ₹9,262.50 | ₹9,087.00 | 485,620 |
|---|
| ₹9,467.00 | +228 | +2.5% | ₹9,239.00 | ₹9,467.00 | ₹9,140.00 | 680,805 |
|---|
| ₹9,239.00 | +179 | +2.0% | ₹9,099.50 | ₹9,270.00 | ₹9,080.50 | 773,225 |
|---|
| ₹9,060.00 | +35 | +0.4% | ₹9,045.00 | ₹9,150.00 | ₹9,035.00 | 527,307 |
|---|
| ₹9,025.00 | +281 | +3.2% | ₹8,739.50 | ₹9,043.00 | ₹8,701.00 | 708,128 |
|---|
| ₹8,744.50 | +249 | +2.9% | ₹8,500.00 | ₹8,744.50 | ₹8,497.00 | 563,721 |
|---|
| ₹8,496.00 | -101 | -1.2% | ₹8,558.50 | ₹8,563.50 | ₹8,457.50 | 251,013 |
|---|
| ₹8,597.00 | +27 | +0.3% | ₹8,600.00 | ₹8,610.00 | ₹8,505.50 | 180,697 |
|---|
| ₹8,570.00 | +10 | +0.1% | ₹8,590.00 | ₹8,597.50 | ₹8,532.00 | 198,190 |
|---|
Splits
3 splits since 2007 · NSE:DIVISLAB · every price before a split is adjusted for it
| Day | Ratio | What |
|---|
| 2-for-1 | Split |
|---|
| 2-for-1 | Split |
|---|
| 5-for-1 | Split |
|---|
- Ticker
- NSE:DIVISLAB
- Asset type
- Stock
- Sector
- Health care
- Industry
- Pharmaceuticals
- Exchange
- NSE
- Currency
- INR
Divi's Laboratories Limited on 6ix
- News releases
- 3 in all · newest Sep 26, 2023 · oldest 2023
Where Divi's Laboratories Limited is listed
| Listing | Exchange | Country | Currency |
|---|
| NSE:DIVISLAB · Home listing · This page | NSE | India | INR |
|---|
| BSE:DIVISLAB | BSE | India | INR |
|---|
Valuation
P/E 101× against a median of 33.8×: the highest of 10 Pharmaceuticals companies shown. Statements: 4 quarters to Jun 30, 2026 · price Nov 20, 2026
- Enterprise value
- ₹2.97T INR
- P/E
- 101×
- EV/sales
- 26.4×
- EV/EBITDA
- 74.8×
- Price/book
- 17.7×
- Gross margin
- 49.9%
- Operating margin
- 31.0%
- Net margin
- 26.1%
- Debt to equity
- 0.0×
- Beta
- No index for this market yet
Pharmaceuticals: the 10 companies nearest in size, of 492 on 6ix with figures. Size in US dollars.
Forecasts
Analysts' consensus from EODHD, read Nov 9, 2026. Not 6ix's view and not investment advice.
- Price target
- 8693.46 INR · Analysts' mean
- EPS, year to Mar 2027
- 127.16 · 27 analysts
- Revenue, year to Mar 2027
- 127.6B · 27 analysts
Team and board
Officers
| Officer | Role |
|---|
| Kiran S. Divi | Whole-Time Director & Chief Executive Officer |
|---|
| Murali K. Divi | Managing Director |
|---|
Board
| Director | Role |
|---|
| Ramesh B.V. Nimmagadda | Non-Executive Chairman & Independent Director |
|---|
| Rajendra Kumar Premchand | Independent Director |
|---|
| Sunaina Singh | Independent Director |
|---|
Events
- Next results
- Feb 6, 2027 (expected)
| Quarter | Results | Share move |
|---|
| Quarter to Sep 30, 2026 | Nov 7, 2026 · Before open | +12.1% |
|---|
| Q1 2027 | Aug 1, 2026 · Before open | +6.6% |
|---|
| Q4 2026 | May 23, 2026 · Before open | −1.9% |
|---|
| Q3 2026 | Feb 11, 2026 · Before open | +3.4% |
|---|
| Q2 2026 | Nov 7, 2025 · Before open | −3.3% |
|---|
| Q1 2026 | Aug 6, 2025 · Before open | −4.3% |
|---|
| Q4 2025 | May 17, 2025 · Before open | +4.8% |
|---|
| Q3 2025 | Feb 3, 2025 · Before open | +4.7% |
|---|
| Q2 2025 | Nov 9, 2024 · Before open | −0.8% |
|---|
| Q1 2025 | Aug 3, 2024 · Before open | −3.3% |
|---|
All 20 quarters
| Quarter | Results | Share move |
|---|
| Q4 2024 | May 25, 2024 · Before open | +3.2% |
|---|
| Q3 2024 | Feb 10, 2024 · Before open | +2.4% |
|---|
| Q2 2024 | Nov 6, 2023 · Before open | +4.7% |
|---|
| Q1 2024 | Aug 14, 2023 · Before open | +1.4% |
|---|
| Q4 2023 | May 20, 2023 · Before open | +5.4% |
|---|
| Q3 2023 | Feb 3, 2023 · Before open | −11.7% |
|---|
| Q2 2023 | Nov 7, 2022 · Before open | −8.9% |
|---|
| Q1 2023 | Aug 12, 2022 · Before open | −5.6% |
|---|
| Q4 2022 | May 23, 2022 · Before open | −9.4% |
|---|
| Q3 2022 | Feb 11, 2022 · Before open | −0.5% |
|---|
Open Events
Financials
Annual, in INR
Income statement
| Line | FY2026 | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 |
|---|
| Revenue | 105.6B | 93.3B | 78.0B | 76.7B | 88.0B | 68.6B | 52.9B | 48.0B | 38.1B | 40.5B |
|---|
| Cost of revenue | 60.0B | 38.7B | 32.7B | 31.8B | 30.9B | 24.3B | 5.59B | 1.96B | 4.79B | 2.38B |
|---|
| Gross profit | 45.6B | 54.5B | 45.3B | 44.9B | 57.1B | 44.3B | 47.3B | 46.1B | 33.3B | 38.2B |
|---|
| Research and development | 400.0M | 270.0M | 350.0M | 300.0M | 202.9M | 149.7M | 111.4M | 106.0M | 101.1M | 119.5M |
|---|
| Selling, general and administrative | 3.16B | 1.43B | 1.25B | 1.26B | 1.09B | 831.4M | 746.9M | 542.3M | 905.3M | 428.1M |
|---|
| Operating income | 29.8B | 25.7B | 18.3B | 20.3B | 35.7B | 26.2B | 16.4B | 17.1B | 11.3B | 13.6B |
|---|
| Depreciation and amortization | 4.63B | 4.02B | 3.78B | 3.43B | 3.12B | 2.56B | 1.86B | 1.69B | 1.42B | 1.23B |
|---|
| EBITDA | 34.4B | 29.7B | 22.1B | 23.7B | 38.9B | 28.7B | 18.3B | 18.8B | 12.7B | 14.9B |
|---|
| Interest expense | 230.0M | 30.0M | 30.0M | 19.6M | 19.9M | 20.9M | 71.3M | 28.5M | 23.5M | 21.7M |
|---|
| Income before tax | 33.9B | 29.2B | 21.6B | 23.7B | 36.8B | 26.7B | 18.2B | 18.6B | 12.3B | 14.0B |
|---|
| Income tax | 8.20B | 7.25B | 5.63B | 5.45B | 7.23B | 6.82B | 4.43B | 5.02B | 3.54B | 3.35B |
|---|
| Net income | 25.7B | 21.9B | 16.0B | 18.2B | 29.6B | 19.8B | 13.8B | 13.5B | 8.77B | 10.6B |
|---|
| Earnings per share, basic | 96.75 | 82.53 | 60.27 | 68.71 | 111.52 | 74.75 | 51.85 | 50.96 | 33.04 | 39.95 |
|---|
Balance sheet
| Line | FY2026 | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 |
|---|
| Cash and equivalents | 1.28B | 4.32B | 3.63B | 1.70B | 12.1B | 20.3B | 431.5M | 130.0M | 251.5M | 207.9M |
|---|
| Short-term investments | 31.1B | 31.2B | 33.4B | 39.7B | 15.3B | 546.4M | 110.1M | 14.0B | 18.9B | 16.3B |
|---|
| Receivables | 31.1B | 29.8B | 21.6B | 17.9B | 24.3B | 16.2B | 14.5B | 585.4M | 433.8M | 9.39B |
|---|
| Inventory | 39.5B | 33.2B | 31.8B | 30.0B | 28.3B | 21.5B | 18.6B | 17.7B | 13.5B | 13.6B |
|---|
| Current assets | 111.0B | 100.8B | 96.8B | 93.1B | 83.5B | 61.7B | 46.8B | 46.5B | 45.4B | 40.1B |
|---|
| Property, plant and equipment | | 64.6B | 55.1B | 49.3B | 47.9B | 44.1B | 37.0B | 25.8B | 21.1B | 20.0B |
|---|
| Total assets | 200.3B | 169.5B | 154.7B | 144.4B | 133.7B | 107.7B | 85.4B | 80.4B | 67.9B | 61.6B |
|---|
| Accounts payable | 12.1B | 9.10B | 8.24B | 7.62B | 7.96B | 7.63B | 5.91B | 4.92B | 4.11B | 4.46B |
|---|
| Current liabilities | 20.4B | 14.5B | 12.8B | 11.0B | 12.0B | 11.1B | 9.27B | 8.47B | 6.53B | 6.59B |
|---|
| Total debt | 70.0M | 40.0M | 30.0M | 44.9M | 36.9M | 48.3M | 388.5M | 1.06B | 631.1M | 357.4M |
|---|
| Total liabilities | 32.7B | 19.8B | 19.0B | 16.7B | 16.5B | 14.8B | 12.3B | 10.8B | 8.61B | 8.01B |
|---|
| Shareholders' equity | 167.6B | 149.7B | 135.7B | 127.7B | 117.3B | 92.9B | 73.1B | 69.6B | 59.2B | 53.6B |
|---|
| Shares outstanding | 265.4M | 265.5M | 265.5M | 265.5M | 265.5M | 265.5M | 265.5M | 265.5M | 265.5M | 265.5M |
|---|
Cash flow
| Line | FY2026 | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 |
|---|
| Cash from operations | 30.2B | 19.5B | 12.6B | 24.6B | 19.1B | 19.5B | 12.2B | 9.54B | 7.76B | 11.5B |
|---|
| Capital spending | -25.2B | -14.4B | -10.0B | -4.73B | -7.13B | -9.10B | -11.8B | -7.33B | -2.74B | -3.77B |
|---|
| Free cash flow | 4.97B | 5.08B | 2.58B | 19.9B | 12.0B | 10.4B | 327.3M | 2.21B | 5.02B | 7.74B |
|---|
| Cash from investing | -25.0B | -11.0B | -2.69B | -27.1B | -21.9B | 751.3M | -834.7M | -6.85B | -4.78B | -11.4B |
|---|
| Cash from financing | -7.99B | -7.97B | -7.99B | -7.97B | -5.32B | -348.9M | -10.9B | -2.46B | -3.14B | 23.8M |
|---|
| Dividends paid | -7.97B | -7.96B | -7.96B | -7.96B | -5.31B | -5.31B | -10.2B | -3.20B | -3.19B | -3.19B |
|---|
| Change in cash | 29.8B | 610.0M | 1.93B | -10.5B | -8.16B | 19.9B | 410.5M | 229.6M | -166.0M | -222.1M |
|---|
Open Financials
Cap table
Built by 6ix from Divi's Laboratories Limited’s releases
- Common shares
- 265,468,580
- Fully diluted
- 265,468,580
Fully diluted
| Line | Shares |
|---|
| Common shares | 265,468,580 |
|---|
Share count over time
| Count | Shares |
|---|
| Nov 22, 2026 | 265,468,580 |
|---|
Open Cap table
Shareholders
| Holder | Shares | Value | As of |
|---|
| Vanguard Total International Stock Index Fund | 1.88M | US$159M | Jul 31, 2026 |
|---|
| Vanguard Emerging Markets Stock Index Fund | 1.78M | US$151M | Jul 31, 2026 |
|---|
| iShares Core MSCI Emerging Markets ETF | 1.32M | US$92.7M | May 31, 2026 |
|---|
| Fidelity Series Emerging Markets Opportunities Fund | 604K | US$51M | Jul 31, 2026 |
|---|
| iShares MSCI India ETF | 580K | US$40.7M | May 31, 2026 |
|---|
| Fidelity SAI Emerging Markets Value Index Fund | 576K | US$48.6M | Jul 31, 2026 |
|---|
| T. Rowe Price Emerging Markets Stock Fund | 479K | US$40.4M | Jul 31, 2026 |
|---|
| Baron Emerging Markets Fund | 430K | US$29.9M | Jun 30, 2026 |
|---|
| T. Rowe Price New Asia Fund | 300K | US$25.3M | Jul 31, 2026 |
|---|
| Vanguard Ftse All-World Ex-Us Index Fund | 299K | US$25.3M | Jul 31, 2026 |
|---|
Show 50 holders
| Holder | Shares | Value | As of |
|---|
| iShares MSCI Emerging Markets ex China ETF | 291K | US$20.4M | May 31, 2026 |
|---|
| iShares MSCI Emerging Markets ETF | 286K | US$20M | May 31, 2026 |
|---|
| Fidelity Series Global ex U.S. Index Fund | 238K | US$20.1M | Jul 31, 2026 |
|---|
| Franklin FTSE India ETF | 207K | US$14.4M | Jun 30, 2026 |
|---|
| State Street(R) SPDR(R) Portfolio Emerging Markets ETF | 205K | US$14.3M | Jun 30, 2026 |
|---|
| Emerging Markets Core Equity 2 Portfolio | 174K | US$14.8M | Jul 31, 2026 |
|---|
| Wasatch Emerging India Fund | 170K | US$11.8M | Jun 30, 2026 |
|---|
| iShares Core MSCI Total International Stock ETF | 166K | US$14M | Jul 31, 2026 |
|---|
| Schwab Emerging Markets Equity ETF | 154K | US$10.8M | May 31, 2026 |
|---|
| Fidelity Emerging Markets Index Fund | 147K | US$12.4M | Jul 31, 2026 |
|---|
| College Retirement Equities Fund - Total Global Stock Account | 114K | US$7.96M | Jun 30, 2026 |
|---|
| Wasatch Emerging Markets Select Fund | 110K | US$7.66M | Jun 30, 2026 |
|---|
| iShares MSCI Emerging Markets Min Vol Factor ETF | 108K | US$7.54M | May 31, 2026 |
|---|
| Vanguard Total World Stock Index Fund | 105K | US$8.86M | Jul 31, 2026 |
|---|
| WisdomTree India Earnings Fund | 103K | US$7.17M | Jun 30, 2026 |
|---|
| Nuveen Emerging Markets Equity Index Fund | 94,140 | US$7.95M | Jul 31, 2026 |
|---|
| Fidelity Total International Index Fund | 69,592 | US$5.88M | Jul 31, 2026 |
|---|
| The Emerging Markets Series | 68,881 | US$5.84M | Jul 31, 2026 |
|---|
| Dimensional Emerging Core Equity Market ETF | 66,502 | US$5.61M | Jul 31, 2026 |
|---|
| Fidelity Emerging Markets Equity Central Fund | 65,356 | US$4.55M | Jun 30, 2026 |
|---|
| Fidelity Global ex U.S. Index Fund | 63,585 | US$5.37M | Jul 31, 2026 |
|---|
| Avantis Emerging Markets Equity ETF | 59,268 | US$4.16M | May 31, 2026 |
|---|
| Matthews India Fund | 47,979 | US$3.34M | Jun 30, 2026 |
|---|
| iShares MSCI ACWI ETF | 44,792 | US$3.78M | Jul 31, 2026 |
|---|
| Wasatch Global Opportunities Fund | 44,305 | US$3.08M | Jun 30, 2026 |
|---|
| T. Rowe Price Institutional Emerging Markets Equity Fund | 43,982 | US$3.71M | Jul 31, 2026 |
|---|
| iShares MSCI All Country Asia ex Japan ETF | 40,338 | US$3.41M | Jul 31, 2026 |
|---|
| Greater India Portfolio | 38,981 | US$2.71M | Jun 30, 2026 |
|---|
| Columbia EM Core ex-China ETF | 37,676 | US$2.62M | Jun 30, 2026 |
|---|
| iShares MSCI ACWI ex U.S. ETF | 36,831 | US$3.11M | Jul 31, 2026 |
|---|
| Fidelity SAI Emerging Markets Index Fund | 36,110 | US$3.05M | Jul 31, 2026 |
|---|
| Tax-Managed International Equity Fund | 31,738 | US$2.68M | Jul 31, 2026 |
|---|
| State Street Global All Cap Equity ex-U.S. Index Portfolio | 31,164 | US$2.17M | Jun 30, 2026 |
|---|
| WisdomTree Emerging Markets ex-State-Owned Enterprises Fund | 31,159 | US$2.17M | Jun 30, 2026 |
|---|
| Dimensional Emerging Markets Core Equity 2 ETF | 28,182 | US$2.38M | Jul 31, 2026 |
|---|
| Emerging Markets Equity Index Fund | 27,970 | US$1.95M | Jun 30, 2026 |
|---|
| Emerging Markets Leaders Portfolio | 27,202 | US$1.89M | Jun 30, 2026 |
|---|
| Vanguard ESG International Stock ETF | 25,694 | US$1.8M | May 31, 2026 |
|---|
| iShares MSCI Global Min Vol Factor ETF | 24,767 | US$1.74M | May 31, 2026 |
|---|
| Goldman Sachs India Equity ETF | 24,480 | US$1.72M | May 31, 2026 |
|---|
This page holds 50 of 117 holders. Open Shareholders
Open Shareholders
People
6ix reads each seat by machine from the page it links to, and can misread one.
| Person | Seat |
|---|
| Kiran S. Divi | Whole-Time Director & Chief Executive Officer · Since at least Nov 6, 2026 |
|---|
| Murali K. Divi | Managing Director · Since at least Nov 6, 2026 |
|---|
| Rajendra Kumar Premchand | Independent Director · Since at least Nov 6, 2026 |
|---|
| Ramesh B.V. Nimmagadda | Non-Executive Chairman & Independent Director · Since at least Nov 6, 2026 |
|---|
| Sunaina Singh | Independent Director · Since at least Nov 6, 2026 |
|---|
Open People
Log in to ask 6ix AI your own questions about Divi's Laboratories Limited.